AstraZeneca PLC
Market cap $262.5B
$169.26
AZN
$169.26
+0.59% today
Buy with €1M virtual cash · No real money
AstraZeneca PLC (AZN) is a publicly traded company listed on the XNYS. As of July 27, 2026, Invest's signal rates AZN a Hold, with the stock up 16% over the past year. You can practice trading AZN risk-free with €1,000,000 in virtual cash.
Key stats
As of July 27, 2026
Market Cap
$262.5B
Volume
2.0M
52-wk High
$212.71
52-wk Low
$142.98
Day High
$170.26
Day Low
$168.33
Performance
1M
-7.5%
6M
-7.7%
1Y
+15.9%
Invest signal · AZN
HoldAlgorithmic signal from price trend, valuation, and fundamentals — educational only, not financial advice.
AZN overview
AI overviewLatest AZN news
Ascentage Pharma Chairman and CEO Dr. Dajun Yang Named to The Medicine Maker Power List 2026
GlobeNewswire Inc. · 5h ago
PD-1 and PD-L1 Inhibitors Clinical Trial Pipeline Analysis Demonstrates 180+ Key Companies on the Horizon Expected to Transform the Oncology Space | DelveInsight
GlobeNewswire Inc. · 5d ago
Clinical Stage Partnering Terms and Agreements in Pharmaceuticals and Biotechnology 2020-2026 | Benchmark More Than 1,800 Biopharma Deals with Various Indexes
GlobeNewswire Inc. · Jul 17
Bioinformatics Collaboration and Licensing Deals 2019-2026 | Compare Upfronts, Milestones, and Royalties for 1,230+ Deals
GlobeNewswire Inc. · Jul 17
Autoimmune Disease Therapeutics Market Size to Reach USD 137.85 Billion by 2035 as Biologics and Precision Medicine Drive Growth | SNS Insider
GlobeNewswire Inc. · Jul 15
About AstraZeneca PLC
A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.
Employees
96,100
30-Day Win Rate · AZN
12 days
11 days
Last 23 sessions
How to practice trading AZN
- 1
Use the AZN buy panel above
Set a quantity and hit Buy at the real market price — right here, nothing to download.
- 2
Trade with €1,000,000 virtual cash
You get a million in virtual money instantly to invest, risk-free.
- 3
Create a free account to save it
Sign up in seconds to keep your portfolio and track its performance.
- 4
Track and compete
Watch your portfolio grow and climb the global leaderboard — or start a private league.
- 5
Prefer mobile? Get the iOS app
Invest is also free on the App Store, synced with your web account.
Top AZN traders on Invest
Full leaderboardFrequently asked questions
Is AZN a good stock to buy right now?
As of July 27, 2026, Invest's signal rates AZN a Hold, based on its price trend, valuation, and fundamentals, with the stock up 16% over the past year. This is an educational signal, not financial advice — the best way to test the thesis is to practice trading AZN risk-free first.
What is AstraZeneca PLC's (AZN) market cap?
AstraZeneca PLC has a market capitalization of approximately $262.5B.
How has AZN stock performed?
AZN is up 16% over the past year and down 8% over six months. Its 52-week range runs roughly from $142.98 to $212.71. Past performance doesn't predict future results.
How can I practice trading AZN for free?
On Invest you get €1,000,000 in virtual cash and can buy AZN at real market prices right in your browser — no download and no real money at risk. Create a free account to save your portfolio and track its performance over time.
More stocks to practice
Designs the iPhone, Mac, and a huge services ecosystem.
Windows, Office, Azure cloud, and enterprise software.
The leading designer of AI and gaming GPUs.
E-commerce giant and the largest cloud provider (AWS).
Google Search, YouTube, Android, and cloud.
Facebook, Instagram, WhatsApp, and the metaverse.
Compare AZN with peers